In brief: Qualcomm partners with Philips, Boehringer Ingelheim to advance connected health
STAMFORD, Conn. – Qualcomm Life’s 2net platform will serve as the medical device connectivity solution for Philips HealthSuite, the company’s cloud-enabled health ecosystem of devices, apps and digital tools. HealthSuite users will now have seamless access to a wide array of connected medical devices, including blood pressure monitors, ventilators, medical grade biosensors and more. Qualcomm Life will use Philips HealthSuite as a global, secure data management and storage solution for its medical-grade 2net platform. Qualcomm Life customers now have direct access to build applications, integrate with electronic health record systems, store normalized data, run analytics, and manage authorizations and consents in a compliant and secure environment. “By collaborating with Qualcomm Life and leveraging its connectivity and wireless expertise, we aim to help care providers to engage better with their patients and contribute to the goal of improving outcomes,” said Jeroen Tas, CEO, connected care and health informatics at Philips, in a press release.
Qualcomm, Boehringer Ingelheim partner on connected inhaler
SAN DIEGO, Calif. – Quallcom is partnering with Boehringer Ingelheim Pharmaceuticals to develop a connected inhaler for COPD patients. Quallcom Life will develop a prototype for a small, wireless, low-power disposable module for Boehringer’s Respimat inhaler, which will connect with Quallcom Life’s 2net platform. The module will be able to track puffs from the Respimat, and the collected information can be shared with the provider or patient. “We are excited to be collaborating with an industry leader like Boehringer Ingelheim to deliver a more seamless digital health experience that can enable COPD patients to better manage their disease,” said Qualcomm Life President Rick Valencia in a press release.
Study finds smartphones can detect atrial fibrillation
ROME, Italy – Smartphones can be used to detect atrial fibrillation with existing hardware, according to a study by the University of Turku, Finland. The study included 16 patients with atrial fibrillation from the Turku Heart Centre and a control group. A smartphone was placed on the chest of the patient, and accelerometer and gyroscope recordings were taken to acquire a heart signal. A measurement recording was taken, and the data was pre-processed by signal processing methods. Autocorrelation and spectral entropy were taken from the pre-processed data, and an algorithm was used to determine if the patient suffered from atrial fibrillation. The technology was able to detect atrial fibrillation with more than 95% sensitivity and specificity. “We measure the actual motion of the heart via miniature accelerometers and gyroscopes that are already installed on today’s smartphones,” said lead author Tero Koivisto in a press release. “No additional hardware is needed and people just need to install an app with the algorithm we developed.” Koivisto said people can perform the test with no assistance from medical staff. “Given the widespread use of smartphones, it has the potential to be used by large populations worldwide,” said Koivisto.
Zillion leverages $28M to enhance digital engagement
NORWALK, Conn. – Zillion Group will use a recent infusion of $28 million to grow and enhance its SaaS-based digital engagement platform. The platform specializes in patient engagement and video consultation to allow healthcare stakeholders to reach patients with greater frequency, allowing them to scale resources, drive revenues and improve outcomes. The technology features face-to-face live video conferencing coupled with dynamic content delivery, as well as interactive messaging, curriculum scheduling, alerts and reminders, monitoring and more. “Zillion’s solution is all about providing a better way of communicating live and a more efficient vehicle to increase engagement, create social networks and virtualize content to deliver optimal patient care and achieve desired outcomes,” said Chairman and CEO Jim Boyle.
Athenahealth buys care coordination platform
WATERTOWN, Mass. – Athenahealth has acquired Filament Labs Inc. (“Patient IO”), an Austin, Texas-based care coordination platform used by providers to engage patients and caregivers outside of a clinic. Through a mobile and web-based application, Patient IO turns care plans into actionable daily tasks for patients, such as managing medications, reviewing educational content and recording self-reported data. Patient IO founders Jason Bornhorst, Colin Anawaty and Brian Gambs will join athenahealth Austin. More than 30 clinical sites currently use Patient IO to coordinate care for their patients. “By adding Patient IO to our portfolio and delivering their solution as a native component of athenahealth’s population health services, we’ve been able to strengthen our ability to partner with providers as they enter into and become masters of value-based care delivery,” said Jon Porter, athenahealth’s senior vice president of emerging services, in a press release. “Patient IO accelerates our movement toward an exciting and strategic milestone: becoming a trusted resource and partner to the patient,” he said.